SpringWorks secures FDA approval of Ogsiveo to treat desmoid tumours
The FDA approval is based on positive data from the Phase 3 DeFi trial, in which Ogsiveo significantly…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Nov 23
The FDA approval is based on positive data from the Phase 3 DeFi trial, in which Ogsiveo significantly…
28 Nov 23
ARCT-032 has been designed to use the firm’s LUNAR lipid-mediated aerosolised platform to provide CFTR messenger RNA to…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
28 Nov 23
In the trial, Dupixent reduced moderate or severe acute COPD exacerbations by 34% over 52 weeks and led…
28 Nov 23
The drug achieved the primary endpoint of progression-free survival and extended the time to disease progression or death…
28 Nov 23
Under the partnership, Boehringer will leverage an AI model developed by IBM, initially pre-trained and subsequently fine-tuned using…
27 Nov 23
Nefecon is a patented, oral delayed-release formulation of budesonide, a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
27 Nov 23
The therapeutic vaccine candidate is currently slated to enter into a Phase 1b trial following the completion of…
Patient CarePharmaceuticals and MedicinesPartnerships and Licensing Agreements
27 Nov 23
The NMPA has also granted Priority Review designation to GFH925 for treating patients with advanced non-small cell lung…
27 Nov 23
With adherence to stringent international regulatory guidelines, the new facility at Pithampur marks a significant leap in manufacturing…
24 Nov 23
The investment is expected to boost the manufacturing site's capability and improve Novo Nordisk's capacity to satisfy future…